share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Officer Dmytruk Mark E.

Ginkgo Bioworks | 4:持股變動聲明-高管 Dmytruk Mark E.

SEC announcement ·  03/08 17:01
Moomoo AI 已提取核心訊息
Mark E. Dmytruk, associated with Ginkgo Bioworks Holdings, Inc. (trading symbol DNA.US), has been involved in a transaction dated 03/07/2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Dmytruk to the issuer is noted as 'See remarks,' suggesting further details might be available in the full report or additional documentation.
Mark E. Dmytruk, associated with Ginkgo Bioworks Holdings, Inc. (trading symbol DNA.US), has been involved in a transaction dated 03/07/2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Dmytruk to the issuer is noted as 'See remarks,' suggesting further details might be available in the full report or additional documentation.
與Ginkgo Bioworks Holdings, Inc.(交易代碼DNA.US)相關的馬克·德米特魯克參與了2024年7月3日的一筆交易。公告中未披露該交易的具體細節,包括股票數量、股票性質、交易價格和股票總價值。Dmytruk與發行人的關係被稱爲 “見備註”,這表明更多細節可能會在報告全文或其他文件中找到。
與Ginkgo Bioworks Holdings, Inc.(交易代碼DNA.US)相關的馬克·德米特魯克參與了2024年7月3日的一筆交易。公告中未披露該交易的具體細節,包括股票數量、股票性質、交易價格和股票總價值。Dmytruk與發行人的關係被稱爲 “見備註”,這表明更多細節可能會在報告全文或其他文件中找到。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息